Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Nov. 12, 2021

Calreticulin as promising new therapeutic target in breast cancer

Nov. 12, 2021

Ascentage Pharma polycomb protein EED inhibitor displays potency, tumor regression potential

Nov. 12, 2021

Biomea Fusion advances BMF-219 for leukemia

Nov. 11, 2021

Monte Rosa selects MRT-2359 as first development candidate

Nov. 11, 2021

Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity

Nov. 11, 2021

XuanZhu Pharma divulges new DNA-dependent protein kinase inhibitors

Nov. 11, 2021

New GnRH-R antagonists identified at Shanghai Innofortune Biotech

Nov. 11, 2021

PharmaBlock Sciences discovers p300 and CREBBP inhibitors

Nov. 11, 2021

New HIF-2alpha inhibitors discovered at NiKang Therapeutics

Nov. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.